Exchange Traded Concepts, LLC Atai Life Sciences N.V. Transaction History

Exchange Traded Concepts, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$2.38 - $3.55 $25,968 - $38,734	10,911 Added 64.25%	27,893 $74,000
Q3 2022 Oct 07, 2022	BUY	$3.14 - $4.87 $11,156 - $17,303	3,553 Added 26.46%	16,982 $56,000
Q2 2022 Jul 20, 2022	BUY	$3.03 - $5.32 $25,055 - $43,991	8,269 Added 160.25%	13,429 $49,000
Q1 2022 Apr 26, 2022	BUY	$4.66 - $7.66 $21,487 - $35,320	4,611 Added 839.89%	5,160 $26,000
Q4 2021 Jan 13, 2022	BUY	$6.82 - $17.8 $3,744 - $9,772	549 New	549 $4,000

12.7M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $206M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.